Outcomes Of Egfr-Mutant Lung Adenocarcinomas (Ac) That Transform To Small Cell Lung Cancer (Sclc).

Nicolas Marcoux,Scott N. Gettinger,Grainne M. O'Kane,Kathryn Cecilia Arbour,Joel W. Neal,Hatim Husain, Tracey L. Evans,Julie R. Brahmer,Alona Muzikansky,Philip Bonomi,Salvatore Del Prete,Anna Wurtz,Anna F. Farago,Dora Dias-Santagata,Mari Mino-Kenudson,Helena Alexandra Yu,Heather A. Wakelee,Frances A. Shepherd,Zofia Piotrowska,Lecia V. Sequist

JOURNAL OF CLINICAL ONCOLOGY（2018）

引用 1|浏览61

暂无评分

摘要

8573Background: 5-10% of EGFR-mutant ACs undergo SCLC/neuroendocrine transformation (SCLC-T) but the clinical course of such pts is poorly characterized. Methods: We identified 50 pts with EGFR-mut...

查看译文

关键词

small cell lung cancer,lung cancer,egfr-mutant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要